Coverage Universe
Companies work with LifeSci Capital because of our distinct influence over investor engagement and behavior
Sort by Sector
Abivax
(ABVX.PA)
Analyst: Sam Slutsky
Immunology and inflammation
Akero Therapeutics
(AKRO)
Analyst: Rami Katkhuda
Immunology and inflammation
ALX Oncology
(ALXO)
Analyst: Sam Slutsky
Oncology
ArriVent
(AVBP)
Analyst: Sam Slutsky
Oncology
Astria Therapeutics
(ATXS)
Analyst: Sam Slutsky
Rare disease
Aura Biosciences
(AURA)
Analyst: Oliver McCammon
Oncology
Avadel
(AVDL)
Analyst: Myriam Belghiti
CNS
Celcuity
(CELC)
Analyst: Oliver McCammon
Oncology
Celldex
(CLDX)
Analyst: Sam Slutsky
Immunology and inflammation
CG Oncology
(CGON)
Analyst: Sam Slutsky
Oncology
Cogent
(COGT)
Analyst: Sam Slutsky
Oncology
Corbus
(CRBP)
Analyst: Oliver McCammon
Oncology
Corbus
(CRBP)
Analyst: Myriam Belghiti
Cardiometabolic
Crescent BioPharma
(CBIO)
Analyst: Charles Zhu
Oncology
Crinetics Pharmaceuticals
(CRNX)
Analyst: Cory Jubinville
Rare disease
DBV Technologies
(DBVT)
Analyst: Sam Slutsky
Immunology and inflammation
Dianthus Therapeutics
(DNTH)
Analyst: Rami Katkhuda
Immunology and inflammation
Disc Medicine
(IRON)
Analyst: Rami Kathkhuda
Hematology
Eledon
(ELDN)
Analyst: Rami Katkhuda
Immunology and inflammation
Enliven Therapeutics
(ELVN)
Analyst: Sam Slutsky
Oncology
Ideaya Biosciences
(IDYA)
Analyst: Charles Zhu
Oncology
Immunome
(IMNM)
Analyst: Charles Zhu
Oncology
Immunovant
(IMVT)
Analyst: Sam Slutsky
Immunology and inflammation
InflaRx
(IFRX)
Analyst: Sam Slutsky
Immunology and inflammation
Inventiva
(IVA)
Analyst: Rami Katkhuda
Immunology and inflammation
Janux
(JANX)
Analyst: Oliver McCammon
Oncology
Kura Oncology
(KURA)
Analyst: Charles Zhu
Oncology
Larimar
(LRMR)
Analyst: Cory Jubinville
Rare disease
Liquidia
(LQDA)
Analyst: Cory Jubinville
Rare disease
Mereo
(MREO)
Analyst: Cory Jubinville
Rare disease
Mersana Therapeutics
(MRSN)
Analyst: Charles Zhu
Oncology
Merus
(MRUS)
Analyst: Charles Zhu
Oncology
Mineralys Therapeutics
(MLYS)
Analyst: Rami Katkhuda
Cardiometabolic
Molecular Partners
(MOLN)
Analyst: Charles Zhu
Oncology
Monte Rosa Therapeutics
(GLUE)
Analyst: Oliver McCammon
Immunology and inflammation
Moonlake Immunotherapeutics
(MLTX)
Analyst: Rami Kathkhuda
Immunology and inflammation
Nuvalent
(NUVL)
Analyst: Charles Zhu
Oncology
Olema
(OLMA)
Analyst: Sam Slutsky
Oncology
OnKure
(OKUR)
Analyst: Sam Slutsky
Oncology
Oruka Therapeutics
(ORKA)
Analyst: Sam Slutsky
Immunology and inflammation
Perspective Therapeutics
(CATX)
Analyst: Oliver McCammon
Oncology
Protara
(TARA)
Analyst: Charles Zhu
Oncology
Pyxis Oncology
(PYXS)
Analyst: Sam Slutsky
Oncology
RAPT Therapeutics
(RAPT)
Analyst: Sam Slutsky
Immunology and inflammation
Repare Therapeutics
(RPTX)
Analyst: Charles Zhu
Oncology
Rocket Pharmaceuticals
(RCKT)
Analyst: Cory Jubinville
Genetic medicines
Scholar Rock
(SRRK)
Analyst: Dennis Kennedy
Rare disease
Soleno
(SLNO)
Analyst: Myriam Belghiti
Rare disease
Spyre Therapeutics
(SYRE)
Analyst: Sam Slutsky
Immunology and inflammation
Structure Therapeutics
(GPCR)
Analyst: Myriam Belghiti
Cardiometabolic
Tarsus
(TARS)
Analyst: Cory Jubinville
Opthalmology
Tectonic
(TECX)
Analyst: Cory Jubinville
Cardiometabolic
Tenaya Therapeutics
(TNYA)
Analyst: Cory Jubinville
Genetic medicines
Tourmaline
(TRML)
Analyst: Rami Katkhuda
Immunology and inflammation
TScan Therapeutics
(TCRX)
Analyst: Sam Slutsky
Oncology
Ventyx
(VTYX)
Analyst: Sam Slutsky
Immunology and inflammation
Vera Therapeutics
(VERA)
Analyst: Rami Katkhuda
Nephrology
Verve
(VERV)
Analyst: Cory Jubinville
Genetic medicines
Viridian Therapeutics
(VRDN)
Analyst: Rami Katkhuda
Immunology and inflammation
VYNE Therapeutics
(VYNE)
Analyst: Rami Katkhuda
Immunology and inflammation
Zymeworks
(ZYME)
Analyst: Charles Zhu